Hanvon(SZ:002362) Zheng Quan Zhi Xing·2025-07-14 13:15Core Viewpoint - Hanwang Technology is experiencing a mixed financial performance, with a projected revenue increase but significant net losses expected for the reporting period [2][3]. Financial Performance - The company anticipates a revenue of 714.54 million yuan, representing a year-on-year increase of 10% to 18% [2]. - The expected net loss ranges from 60 million yuan to 45 million yuan, with a specific loss attributed to shareholders of 50.80 million yuan, reflecting a decline of 18.10% to 11.42% compared to the previous year [2]. - The net loss after excluding non-recurring items is projected to be 55.02 million yuan, indicating a decrease of 27.24% to 9.12% year-on-year [2]. - Basic earnings per share are expected to be a loss between 0.2454 yuan and 0.1841 yuan, compared to a loss of 0.2078 yuan per share in the previous year [2]. Business Segments - The digital painting business is expected to see a sales revenue growth of 20% to 25%, with significant growth in both domestic and overseas markets [3]. - The AI reading and writing smart notebooks and readers are projected to grow by 45% to 55% in sales revenue, with gross profit growth outpacing expense growth [3]. - The AI Koshian electronic blood pressure monitor is gaining market recognition, with substantial expected sales revenue growth [3]. R&D Investment - The company continues to invest heavily in R&D, with a year-on-year increase in R&D expenses [4]. - Investments are being made in cutting-edge technologies, including large model technology, bionic robotics, and olfactory recognition technology, which are still in the incubation stage and may not yield immediate financial benefits [4].